UK and Ireland Combatting CDI Event

 

Clostridioides difficile remains an important healthcare associated infection. Despite previous reductions in UK CDI cases, these increased by 20% from 2022 to 2023 (14,249 vs 17,216). Importantly, Patient and Public Involvement work by the applicants tells us the disease is far-reaching, affecting both physical and mental health, sometimes for prolonged periods.

The UK and Ireland Combatting CDI meeting 2024 is a UK and Ireland event, being hosted by Public Health Wales, and covering all aspects of C. difficile infection (including diagnosis, IPC, antimicrobial resistance, treatment, epidemiology and typing). Crucially, this event will start and end with patient and carer experiences of CDI, and will include an update on the development of the UK CDI Trust, a patient information and advocacy organisation. This will put the patient at the heart of discussions about CDI at this meeting.

The event builds on the highly successful 2022 Wales C. difficile awareness Day, expanding to a UK and Ireland event, and attracting international experts as speakers and chairs (PHW Combatting CDI Conference 2024.

The event was a hybrid and reached capacity for in-person attendance. Over 320 delegates registered from the following countries: Wales, England, Scotland, Northern Ireland, Republic of Ireland, USA, Italy, Egypt, Romania, Switzerland, Australia, Saudi Arabia, Armenia, Czechia, Croatia, Spain, Netherlands, Portugal, India, Germany, Portugal, Greece, Serbia and Turkey. .

The event aimed to provide education and information on what is currently known - and not known - about C. difficile, the disease it causes, the epidemiology and the state-of-the-art in preventing and treating CDI. Importantly, it will also bring the CDI patient voice

The learning outcomes were:

• an increased awareness/appreciation of what the impact of CDI is on patients and carers

• an awareness of the UK & Ireland CDI Trust - a patient information and advocacy group being established

• an awareness of IPC strategies for tackling CDI, including behaviour change and clinical leadership

 • knowledge of the latest C. difficile epidemiology and typing approaches from England, Ireland, Northern Ireland, Scotland and Wales

• increased knowledge of CDI outside the hospital: diagnosis, collaborative projects and pharmacy best practise, dentistry and the One health agenda

• knowledge of the latest scientific research in C. difficile (microbiome, biofilms and susceptibility testing)

• an appreciation of current CDI treatment guidelines, and awareness of treatments on the horizon

• appreciation of current CDI research through poster sessions.